Re: Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
Toiyama et al. have demonstrated for the first time that high levels of miR-21, not only in colorectal cancer (CRC) tissues but also in serum, are associated with tumor size, distant metastasis, and poor survival (1) . This report is elegant and meaningful in that the authors found "serum" miR-21 as a promising biomarker for CRC, which enables noninvasive detection and evaluation of CRC. There are three issues we would like to address.
First, although the authors determined miR-21 expression levels in serum samples (1) , it would be interesting to investigate whether miR-21 derived from exosomes (2) would also act as a diagnostic biomarker for CRC when isolated from peripheral blood. As shown by the authors (1), miR-21 is a secreted miRNA. Actually, tumors actively release exosomes into peripheral circulation, and circulating exosomes can be collected and isolated. Serum-derived miR-21 reflects total amounts of secreted miR-21, whereas "purified" exosomederived miR-21 reflects only a part of it (3). Interestingly, Taylor et al. elegantly demonstrated that tumor-derived exosomes are useful as diagnostic biomarkers of ovarian cancer (4). In CRC, it would be valuable to determine which would be more closely associated with tumor progression, serumderived miR-21 or exosome-derived miR-21.
Second, postoperative reductions in serum miR-21 levels occurred exclusively among patients with potentially curative surgeries (1). Because chemotherapy was administered to patients with stage III/IV disease in the study (1) , it would be interesting to examine whether there were postchemotherapy reductions in serum miR-21, reflecting responsiveness to chemotherapy. Furthermore, regardless of chemotherapy, ascertaining whether serum miR-21 would serve as a long-term follow-up biomarker (like tumor marker) would be of interest.
Finally, as speculated in the accompanying editorial by Stintzing and Lenz (5), miR-21 serum levels might be elevated in CRC as a sign of an inflammatory process of adjacent healthy tissues. If this hypothesis were true, is there any evidence that postmedication reductions in serum miR-21 levels occurred in patients who received administration of anti-inflammatory drugs, such as steroids or nonsteroidal anti-inflammatory drugs (NSAIDs)? Because NSAIDs have been shown to play a role in disease prevention in CRC (6,7), further elucidation on the putative relationship between miR-21 and NSAIDs might be useful.
